Shanghai Bao Pharmaceuticals Co Ltd HKEX:2659:
NMPA APPROVES IND APPLICATION FOR BJ044 INJECTION, PERMITTING CLINICAL TRIALS
Reuters
Shanghai Bao Pharmaceuticals Says NMPA Approves IND Application For BJ044 Injection
- Sources
- Reuters
- Markets
- Stocks
- Active symbols
- HKEX:2659
- Language
- English
Shanghai Bao Pharmaceuticals Co Ltd HKEX:2659: